John Murphy, M.D., Joins NavaDerm as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Mizuho Securities Reiterates Buy Rating on Humana (HUM) Following 3Q Beat
November 7, 2019 6:52 AM ESTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $316.00 price target on Humana (NYSE: HUM) following the company's 3Q earnings release. HUM reported 3Q results with a beat on adjusted EPS, revenue and adjusted operating profit. Adjusted EPS of $5.03 beat guidance of $4.58. Total... More
